# FDA Inspection 1106642 - Baxter Oncology GmbH - September 03, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/65040e4f-1fd6-4b4b-acff-6fa84596b810
Source feed: FDA_Inspections

> FDA Inspection 1106642 for Baxter Oncology GmbH on September 03, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106642
- Company Name: Baxter Oncology GmbH
- Inspection Date: 2019-09-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283802 - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29)
- [FDA Inspection 1206312 - 2023-05-03](https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6)
- [FDA Inspection 1161093 - 2020-01-29](https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/a02d317d-bca9-4a63-ac97-f10e78abf4af)
- [FDA Inspection 1056958 - 2018-06-14](https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/9da172d1-9118-487f-b26d-5b064e49e5f1)
- [FDA Inspection 1019700 - 2017-06-27](https://www.globalkeysolutions.net/records/fda_inspections/baxter-oncology-gmbh/64eef675-4ce9-4232-82e4-ae06945fe393)

Company: https://www.globalkeysolutions.net/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c